Monday, April 28, 2025

Clowes Developments Announces Macmillan Cancer Support as 2025/26 Chosen Charity

Clowes Developments are proud to announce that Macmillan Cancer Support has been elected as the group’s Charity of the Year for the financial period 1st April 2025 to 31st March 2026, following their annual employee-led nomination and voting process.

Each year, employees are invited to nominate charities they are passionate about. These nominations are carefully reviewed to ensure alignment with the group’s values before being put to a company-wide vote. This inclusive approach helps ensure that the selected charity is meaningful to the team and reflects the causes closest to their collective hearts.

This year, the vote to support Macmillan Cancer Support holds special significance. 2025 marks the 10-year anniversary of the passing of the group’s founder, Charles Clowes and also a time to honour the memory of their much loved colleague and friend, Paul Turner, who sadly passed away earlier this year. In their memory, the group has chosen to support a cancer charity that provides critical help to people and families affected by cancer across the UK.

Macmillan estimate that almost 3.5 million people in the UK are currently living with cancer, a figure projected to rise to 4 million by 2030. Receiving a diagnosis can be overwhelming, impacting not just health but also finances, work and emotional wellbeing. Macmillan is there to help people live life as fully as possible, providing compassionate physical, financial and emotional support every step of the way.

In 2023 alone:

· Macmillan supported over 2.3 million people affected by cancer – 250,000 more than in 2022

· Their nurses and support workers reached approximately 730,000 people

· They helped identify £310 million in benefits through local welfare rights services

· Supporters and fundraisers raised an incredible £226.8 million

Clowes Developments Managing Director, Thomas Clowes commented:

“We are excited to contribute to Macmillan’s extraordinary efforts through a series of fundraising events and initiatives over the next 12 months. Further details of our activities will be shared in due course as we rally together to make a meaningful impact.

We would also like to take this opportunity to celebrate the success of our previous fundraising year. From 1st April 2024 to 31st March 2025, the group raised an impressive £7,102.61 in support of Derbyshire Mind, our former charity partner. We are incredibly grateful to all employees, supporters and donors who contributed to this achievement.”

A message from the Editor:

Thank you for reading this story on our news site - please take a moment to read this important message:

As you know, our aim is to bring you, the reader, an editorially led news site and magazine but journalism costs money and we rely on advertising, print and digital revenues to help to support them.

With the Covid-19 pandemic having a major impact on our industry as a whole, the advertising revenues we normally receive, which helps us cover the cost of our journalists and this website, have been drastically affected.

As such we need your help. If you can support our news sites/magazines with either a small donation of even £1, or a subscription to our magazine, which costs just £33.60 per year, (inc p&P and mailed direct to your door) your generosity will help us weather the storm and continue in our quest to deliver quality journalism.

As a subscriber, you will have unlimited access to our web site and magazine. You'll also be offered VIP invitations to our events, preferential rates to all our awards and get access to exclusive newsletters and content.

Just click here to subscribe and in the meantime may I wish you the very best.









Latest news

Related news

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close